npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

AGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.

Mitochondrial DNA Part B-Resources, published by TAYLOR & FRANCIS LTD, is a prominent academic journal focusing on the vast and evolving field of genetics and molecular biology. As an open access resource, it is dedicated to providing valuable insights and comprehensive data on mitochondrial DNA, an area crucial for understanding cellular functions, genetic inheritance, and various diseases. Although relatively new, having commenced in 2016, the journal has gained recognition with its current Scopus rankings placing it in the lower quartiles for both Genetics and Molecular Biology. It serves as an essential platform for researchers, professionals, and students at the intersection of genetics and biotechnology, fostering collaboration and innovation. With a commitment to quality research and accessibility, Mitochondrial DNA Part B-Resources is poised to contribute significantly to the scientific community until at least 2024 and beyond.

ACTA ZOOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, published by the Hungarian Natural History Museum, is a distinguished open access journal dedicated to advancing knowledge across the fields of Animal Science, Zoology, Ecology, Evolution, Behavior, and Systematics. Established in 2003 as an open access platform, this scholarly journal has actively contributed to the dissemination of critical research since 1996, positioning itself within the Q3 quartile in both its primary fields as of 2023. With its ISSN 1217-8837, ACTA ZOOLOGICA serves as a vital resource for researchers, professionals, and students aiming to explore and expand their understanding of animal biodiversity and ecology. Its publication features a variety of empirical studies, reviews, and critical commentaries that rigorously address contemporary issues in zoological sciences, underlining its commitment to fostering academic excellence and environmental sustainability. Researchers can access the journal’s extensive archives to deepen their inquiry into animal life, making it an essential addition to any academic library.

Aging and Disease is a leading open-access journal published by the International Society on Aging and Disease, dedicated to advancing the understanding of aging and its associated diseases. Since its inception in 2010, the journal has established itself as a vital resource for researchers and practitioners in the fields of Geriatrics, Neurology, Cell Biology, and Pathology. With an impressive Q1 ranking across multiple categories and a robust position in Scopus rankings, including ranks in the top 3% in Geriatrics and Gerontology, it showcases high-quality research that addresses the complexities of aging processes. Each issue presents original articles, reviews, and insights aimed at improving health outcomes for the aging population. The open-access model ensures that valuable research findings are readily available to a global audience, fostering collaboration and innovation. As a go-to publication for scholars, healthcare professionals, and students, Aging and Disease significantly contributes to the multidisciplinary dialogue surrounding aging and its health implications.

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.

Physiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.

Mitochondrial DNA Part A, published by Taylor & Francis Ltd, is a distinguished journal dedicated to the exploration of mitochondrial genetics and its implications for health and disease. With an ISSN of 2470-1394 and an E-ISSN of 2470-1408, this journal serves as an open-access platform, promoting the dissemination of high-quality research in the field. Operating from the United Kingdom, it offers a vital resource for researchers and professionals keen to delve into the rapidly evolving landscape of mitochondrial studies. Although currently ranked Q4 in both the Genetics and Molecular Biology categories, the journal continues to be a valuable outlet for emerging findings that could impact our understanding of cellular processes and hereditary conditions. Researchers can access articles and data covering recent advancements from 2016 through 2022, with ongoing contributions expected in 2024. As the field grows, so too does the importance of this journal as a source of knowledge and collaboration for the academic community.